• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-induced subacute cutaneous lupus erythematosus involving osimertinib.

作者信息

Bailey-Burke Christian L, Nousari Carlos H, Wangia Michael W

机构信息

Duke University School of Medicine, Durham, North Carolina.

Department of Dermatology, University of Miami, Miami, Florida.

出版信息

JAAD Case Rep. 2024 Sep 19;53:177-180. doi: 10.1016/j.jdcr.2024.08.032. eCollection 2024 Nov.

DOI:10.1016/j.jdcr.2024.08.032
PMID:39555307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11564780/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/1b26e2342a58/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/167d8477deda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/68be41c07a60/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/1b26e2342a58/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/167d8477deda/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/68be41c07a60/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa0/11564780/1b26e2342a58/gr3.jpg

相似文献

1
Drug-induced subacute cutaneous lupus erythematosus involving osimertinib.药物性亚急性皮肤型红斑狼疮，涉及奥希替尼。
JAAD Case Rep. 2024 Sep 19;53:177-180. doi: 10.1016/j.jdcr.2024.08.032. eCollection 2024 Nov.
2
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in -Mutated Non-small Cell Lung Cancer: A Case Report.表皮生长因子受体酪氨酸激酶抑制剂诱发的具有亚急性皮肤型红斑狼疮样皮疹的KRAS基因突变非小细胞肺癌：一例报告
Front Med (Lausanne). 2021 Jun 4;8:570921. doi: 10.3389/fmed.2021.570921. eCollection 2021.
3
Drug-induced cutaneous lupus erythematosus: 88 new cases.药物性皮肤型红斑狼疮：88例新病例。
Eur J Dermatol. 2017 Feb 1;27(1):28-33. doi: 10.1684/ejd.2016.2912.
4
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.特发性与药物诱导的亚急性皮肤型狼疮是否具有独特的临床和病理特征？一项欧洲回顾性多中心研究。
J Am Acad Dermatol. 2019 Aug;81(2):403-411. doi: 10.1016/j.jaad.2019.02.009. Epub 2019 Feb 11.
5
A systematic review of drug-induced subacute cutaneous lupus erythematosus.药物诱导的亚急性皮肤型狼疮的系统性综述。
Br J Dermatol. 2011 Mar;164(3):465-72. doi: 10.1111/j.1365-2133.2010.10110.x. Epub 2011 Feb 17.
6
Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series.既往诊断为系统性红斑狼疮患者的药物性亚急性皮肤型红斑狼疮：病例系列
JAAD Case Rep. 2021 Apr 9;12:18-21. doi: 10.1016/j.jdcr.2021.03.048. eCollection 2021 Jun.
7
Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.药物诱导的亚急性皮肤型红斑狼疮：与特发性疾病相比的证据。
Br J Dermatol. 2011 Aug;165(2):335-41. doi: 10.1111/j.1365-2133.2011.10397.x. Epub 2011 Jul 11.
8
Drug-induced lupus erythematosus.药物性红斑狼疮。
G Ital Dermatol Venereol. 2014 Jun;149(3):301-9.
9
Atypical Subacute Cutaneous Lupus in a Patient on Apixaban Anticoagulation Therapy: A Case Report and Review of the Literature.阿哌沙班抗凝治疗患者的非典型亚急性皮肤型狼疮：一例报告并文献复习
Cureus. 2021 Jul 22;13(7):e16571. doi: 10.7759/cureus.16571. eCollection 2021 Jul.
10
Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.亚急性皮肤型红斑狼疮与盘状红斑狼疮的临床、组织学及免疫荧光鉴别
J Invest Dermatol. 1992 Sep;99(3):251-7. doi: 10.1111/1523-1747.ep12616582.

本文引用的文献

1
Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance.奥希替尼耐药的表皮生长因子受体突变型非小细胞肺癌患者的治疗策略。
J Hematol Oncol. 2022 Dec 8;15(1):173. doi: 10.1186/s13045-022-01391-4.
2
Nivolumab-Induced de novo Discoid Lupus Erythematosus.纳武单抗诱发的新发盘状红斑狼疮
Case Rep Dermatol. 2022 Apr 21;14(1):88-92. doi: 10.1159/000523800. eCollection 2022 Jan-Apr.
3
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.
度伐利尤单抗诱导的亚急性皮肤型红斑狼疮样皮疹：一例报告及文献复习
Clin Cosmet Investig Dermatol. 2022 Jan 13;15:51-62. doi: 10.2147/CCID.S344445. eCollection 2022.
4
Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs.药物诱导的皮肤性狼疮：临床和免疫学特征及新的相关药物更新。
Ann Dermatol Venereol. 2021 Dec;148(4):211-220. doi: 10.1016/j.annder.2021.02.006. Epub 2021 Oct 26.
5
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in -Mutated Non-small Cell Lung Cancer: A Case Report.表皮生长因子受体酪氨酸激酶抑制剂诱发的具有亚急性皮肤型红斑狼疮样皮疹的KRAS基因突变非小细胞肺癌：一例报告
Front Med (Lausanne). 2021 Jun 4;8:570921. doi: 10.3389/fmed.2021.570921. eCollection 2021.
6
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Lung Cancer: History, Epidemiology, and Market Outlook.表皮生长因子受体酪氨酸激酶抑制剂与肺癌：历史、流行病学及市场展望
Cureus. 2021 Feb 21;13(2):e13470. doi: 10.7759/cureus.13470.
7
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.奥希替尼：肺癌患者的一种新型皮肤不良反应特征。
Oncologist. 2018 Aug;23(8):891-899. doi: 10.1634/theoncologist.2017-0582. Epub 2018 Apr 12.